" data-cookies-message="By continuing to browse this site, you agree to the use of third-party cookies or similar technologies designed to identify and analyze your interests. To continue browsing this site, click CLOSE and/or continue browsing." data-cookies-policy-url="//m.jiahe-window.com/en.media/news/#">

医疗保健:在美国的太平洋科学收购

5月28日,2009年5月28日

Air Liquide的医疗保健业务正在追求其发展美国收购Pacific Sc​​ience,Inc,Crybiology设备和生物银行服务提供者, based in Torrance, California. The transaction, effective May 1, was made by Air Liquide Healthcare America Corporation, Air Liquide’s American Healthcare subsidiary.

Cryobiology is a promising area for Air Liquide. Across the world, Air Liquide helps ensure thequality and the operability储存生物样品。北美占该快速增长市场的40%以上,其位于东部和西海岸的最具活力的市场。

太平洋科技有限公司, a 15 people company, will complement Air Liquide’s offering to American hospitals, particularly on the West Coast. It is also a channel through which Air Liquide’s cryobiology solutions can be brought to the U.S. market. They include designs for biobanks, vacuum line installations, liquid nitrogen supply, freezing and storage capacity, global process monitoring and cell tracking.

Jean-Marc de Royere,负责医疗保健高级副总裁和AIR LIQUIDE执行委员会的成员:“We are pleased to welcome Pacific Science into our Healthcare organization. We value the expertise they have developed as a dedicated services outfit. With this latest acquisition in the United States, we can bring biobanks the comprehensive offering that many expect.”

Download the pdf

top_page.